[{"id":"83fb8ec7-113b-40ac-abe0-a62e72250dc3","acronym":"","url":"https://clinicaltrials.gov/study/NCT03423628","created_at":"2021-01-18T16:53:18.718Z","updated_at":"2024-07-02T16:35:02.625Z","phase":"Phase 1","brief_title":"A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer","source_id_and_acronym":"NCT03423628","lead_sponsor":"AstraZeneca","biomarkers":" IDH1","pipe":" | ","alterations":" IDH1 mutation","tags":["IDH1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IDH1 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AZD1390"],"overall_status":"Recruiting","enrollment":" Enrollment 120","initiation":"Initiation: 04/02/2018","start_date":" 04/02/2018","primary_txt":" Primary completion: 04/22/2026","primary_completion_date":" 04/22/2026","study_txt":" Completion: 04/22/2026","study_completion_date":" 04/22/2026","last_update_posted":"2024-05-20"}]